Reducing the risk of infection from plasma products: specific preventative strategies
- 30 June 2000
- journal article
- review article
- Published by Elsevier in Blood Reviews
- Vol. 14 (2), 94-110
- https://doi.org/10.1054/blre.2000.0129
Abstract
No abstract availableKeywords
This publication has 97 references indexed in Scilit:
- Summary of a Food and Drug Administration workshop on nucleic acid testing to screen donations of blood and plasma for the hepatitis C virusTransfusion, 1999
- Virus reduction in the preparation of intravenous immune globulin: in vitro experimentsTransfusion, 1999
- Inactivation of viruses by β-propiolactone in human cyro poor plasma and IgG concentratesBiologicals, 1998
- Research and Development Commitments in an Integrated Plasma Collection and Plasma Fractionation EnvironmentSeminars in Thrombosis and Hemostasis, 1998
- Transmission of hepatitis G virus in patients with angioedema treated with steam‐heated plasma concentrates of C1 inhibitorTransfusion, 1998
- Strategies for viral inactivationCurrent Opinion in Hematology, 1995
- Low risk of transmission of hepatitis E virus by large-pool coagulation factor concentratesThe Lancet, 1994
- Potential deferral criteria predictive of human immunodeficiency virus positivity among blood donors in ThailandTransfusion, 1994
- Validation of Virus Inactivation and Removal for the Manufacturing Procedure of Two Immunogiobulins and a 5% Serum Protein Solution Treated with β-PropiolactoneBiologicals, 1993
- Reduced risk of non‐A, non‐B hepatitis after a first exposure to ‘wet heated’factor VIII concentrateBritish Journal of Haematology, 1987